retatrutide launch 🚨 BREAKING PEPTIDE NEWS just took another major step forward—but don't confuse early access with FDA approval. Eli Lilly has opened a limited Expanded Access Program for certain adults with severe Subscription:1 month collection:weightloss Episode 80: An Intro

retatrutide launch 🚨 BREAKING PEPTIDE NEWS just took another major step forward—but don't confuse early access with FDA approval. Eli Lilly has opened a limited Expanded Access Program for certain adults with severe Subscription:1 month collection:weightloss Episode 80: An Intro

Episode 80: An Intro to GLP-1 & Weight Loss with Stacy Walker, NP

In one trial where participants did not use CPAP, Zepbound reduced AHI events by an average of 25 per hour after one year, compared to a reduction of just five events in the placebo group

collection:weightloss

Subscription:1 month

[DOI] [PubMed] [Google Scholar] 57.De Cicco M., Mamone G., Di Stasio L., Ferranti P., Addeo F., Picariello G